A phase 2 pilot study of MYMD-1 in Hashimoto's thyroiditis
Latest Information Update: 23 Aug 2024
At a glance
- Drugs Isomyosamine (Primary)
- Indications Lymphomatous thyroiditis
- Focus Therapeutic Use
Most Recent Events
- 23 Aug 2024 New trial record
- 21 Aug 2024 According to a TNF Pharmaceuticals media release, FDA-cleared IND for a Phase 2 pilot study of MYMD-1 for MYMD-1 in Hashimoto's thyroiditis.